4-Phenylbutyric acid

产品说明书

Print
Chemical Structure| 1821-12-1 同义名 : 苯丁酸 ;4-PBA; Benzenebutyric acid
CAS号 : 1821-12-1
货号 : A148817
分子式 : C10H12O2
纯度 : 98%
分子量 : 164.2
MDL号 : MFCD00004403
存储条件:

Pure form Sealed in dry,2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(639.46 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 2 mg/mL(12.18 mM),配合低频超声助溶

动物实验配方:
生物活性
描述 4-Phenylbutyric acid (4-PBA), known as an inhibitor of histone deacetylases (HDAC), effectively inhibits the growth of non-small cell lung cancer (NSCLC) cell lines at a concentration of 2 mM. When combined with ciglitizone, 4-Phenylbutyric acid further enhances the growth arrest of cancer cells[1]. Additionally, 4-Phenylbutyric acid, at concentrations ranging from 0 to 5 mM, dose-dependently inhibits African swine fever virus (ASFV) infection. 4-Phenylbutyric acid also disrupts ASFV-induced hypoacetylation of histone H3 at lysines 9 and 14 and inhibits late protein synthesis by the virus. The synergistic effect of 4-Phenylbutyric acid with enrofloxacin significantly eliminates ASFV replication[2]. The introduction of bafilomycin A1 leads to an increase in the accumulation of LC3II, a marker for autophagy, whereas 4-Phenylbutyric acid (4-PBA) substantially reduces this buildup. Lipopolysaccharide (LPS) lowers p62 levels, a process that is reversed by Benzenebutyric acid after 48 hours of LPS stimulation. Furthermore, while LPS increases the percentage of cells with acidotic vesicular organelles (AVOs) at 48 hours, 4-Phenylbutyric acid significantly lowers this percentage. Specifically, treatment with Benzenebutyric acid reduces the percentage of cells with AVOs from 61.6% to 53.1%, indicating that 4-Phenylbutyric acid inhibits LPS-induced autophagy[3].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

6.09mL

1.22mL

0.61mL

30.45mL

6.09mL

3.05mL

60.90mL

12.18mL

6.09mL

参考文献

[1]Chang TH, et al. Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung. Clin Cancer Res. 2002 Apr;8(4):1206-12

[2]Frouco G, et, al. Sodium phenylbutyrate abrogates African swine fever virus replication by disrupting the virus-induced hypoacetylation status of histone H3K9/K14. Virus Res. 2017 Oct 15;242:24-29.

[3]Park HJ, et al. 4-Phenylbutyric acid protects against lipopolysaccharide-induced bone loss by modulating autophagy in osteoclasts. Biochem Pharmacol. 2018 May;151:9-17.